Clarus Ventures
American biotherapeutics-focused fund with a barbell investment strategy between early stage disruptive platforms and Phase III defined exit deals
Secteur: Life Sciences
Genesys Capital
Toronto-based early stage life sciences fund focused on building companies in the high-growth sectors of healthcare and biotechnology
Lumira Ventures
Life sciences venture capital firm investing in biotechnology and medical device companies from early to late stage across North America
Persistence Capital Partners
Healthcare-focused fund dedicated to buyout and growth opportunities across Canada in healthcare services and technologies
Sofinnova Partners
Pan-European fund creating and building entrepreneur-driven companies in biotechnology and medical devices
Versant Ventures
Californian venture firm operating incubators in Canada and investing through self-sustaining drug development units
Zymeworks
Zymeworks is a biotherapeutics company that is developing best-in-class Azymetric bi-specific antibodies and antibody drug conjugates for the treatment of cancer, autoimmune and inflammatory diseases
CTI Sciences de la Vie
Life sciences venture capital fund investing in early-stage biotechnology companies across Canada, the United States and Europe
Lumira Ventures
Life sciences venture capital firm investing in biotechnology and medical device companies from early to late stage across North America
Merck Lumira
Québec-based fund dedicated to start-up companies in life sciences in partnership with Merck